The COVID-19 pandemic has given us a new appreciation for the role of public health. While our public health departments and hospitals continue to manage vaccination and cases resulting from new variants, we also know that those of you battling C. diff infections still need our help. Please know that …
Last month our executive director and two members of our Advocates Council, Christina Fuhrman and Eric Petrosinelli, joined the Pew Charitable Trusts “Stand Up to Superbugs” fly-in. They joined 37 other Americans from all across the country to meet with the representatives to share their superbug stories and expertise and …
Fecal microbiota transplant (FMT) as a treatment for C. difficile infections has skyrocketed over the past decade. While it has saved tens of thousands of lives, FMT remains controversial and the Food and Drug Administration (FDA) has been slow to formalize its regulatory status. This has left doctors, scientists, drug …
The Food and Drug Administration (FDA) issued a Safety Alert today Regarding Use of Fecal Microbiota for Transplantation and Additional Safety Protections Pertaining to COVID-19. According to the alert, “FDA is informing health care providers and patients of the potential risk of transmission of SARS-CoV-2 virus by the use of fecal …
On March 12, the Food and Drug Administration (FDA) issued a safety alert that eight patients were infected following fecal microbiota transplants (FMT) using material from a company which was later confirmed to be OpenBiome, an independent stool bank. Two of the patients subsequently died. FDA did not name OpenBiome …
